Download Medical Notes on Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations

Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations Medical Notes

About This Presentation

Description:This report titled, “Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations” is by the IQVIA Institute and is an analysis of the orphan drug market. The report explores this topic of orphan drugs’ orphan and non-orphan indication approvals and their associated patent and market exclusivities. The report also examines orphan drug pricing relative to patient numbers, how those prices change over time, and – in a first-of-its-kind comprehensive analysis – compares current disease epidemiology to the number of treated patients to demonstrate the challenges in bringing orphan drugs to patients even after they are approved.

Tags:Healthcare, Orphan Drugs, United States, market, pricing, disease epidemiology

Published on: Jul 20, 2020 | Views : 1714 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

Importance of food we eat and physical activity etc on our wellness

About : I am a passionate medical marketing professional with hands on experience in healthcare digital marketing.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : India
Website :

Importance of food we eat and physical activity etc on our wellness

Advancing Human Data Science - A NEW APPROACH TO IMPROVING HUMAN HEALTH OUTCOMES

Upliftment of OTC Medicines Towards Innovative Marketing Strategies

Understanding Neuromuscular Disease Care Current State and Future Prospects

The Impact of COVID-19 on Cancer Treatment in Spain

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 3

Hospital Pharmacy Compliance Handbook

EvaluatePharma pharmaceutical industry world review 2019 and outlook 2024

EvaluatePharma Orphan Drug Report 2020

Global pharma and Indian pharmaceutical industry: Prospects for growth

HEALTH A TO Z